PSNL Personalis Corp Gross Profit Margin

PSNL (Personalis Inc) - company brandmark

The gross margin chart illustrates the implementation of ultra-deep sequencing in oncology to create personalized therapy plans for Personalis, Inc. (PSNL). However, 16.70 reflects the current value of the metric, accounting for liquidity shortage risks and slow insurance coverage. Additionally, geopolitical barriers and strict export controls on medical data in developed countries are weighing on financial performance.

PSNL - Personalis, Inc. Gross Margin over the range 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for personalis.com (PSNL)

- current quotes and average value forecast:
Basic company analysis:PSNL - Personalis Corp
Finished products of Personalis, Inc.

Investors should utilize this metric to stress-test business resilience by evaluating the profit margin after deducting direct production costs. For Personalis, Inc. (PSNL), which combines elite bioinformaticians with high-cost DNA sequencing equipment, the gross margin reflects the efficiency of monetizing scientific developments, determining whether the generated revenue offsets the high cost of intellectual labor and resources.

Key competitors

Gross Profit Margin BeiGene Ltd. (ONC)|Return on Gross Profit HALO|Gross Profitability RVMD|Return on Gross Profit AAPG (Ascentage)|Return on Gross Profit cgoncology.com CGON|UroGen Pharma - Return on Gross Profit|Gross Profit Rate BCAX|Erasca Oncology - Gross Margin|Gross Profit Rate DCTH (Delcath Corp)|YMAB: Gross Margin|AURA - Return on Sales by Gross Profit|CADL (Candel Therapeutics Inc.) - Gross Margin|Gross Return on Sales ARAY (Accuray)|Return on Gross Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Gross Profit Margin|Gross Profitability Citius Oncology, Inc. CTOR|HURA - Return on Gross Profit|protaratx.com - Gross Margin|FATE - Gross Margin|WHWK: Gross Margin|TScan Therapeutics (TCRX) - Gross Margin|Gross Profitability Champions Oncology|Gross Profitability XBIT|Gross Margin CVM|Return on Gross Profit OS Therapies Inc. OSTX|Gross Profitability Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Gross Profit Margin|ANL - Gross Profitability|Gross Profit Margin verupharma.com|TPST: Gross Margin|XLO - Return on Sales by Gross Profit|Gross Profitability Renovaro|Gross Margin muraloncology.com|Gross Margin KAPA|Return on Sales by Gross Profit OnKure Therapeutics, Inc.|Gross Margin GDTC (w2.cytomed.sg)|CRIS - Return on Gross Profit|Apollomics - Gross Margin|Tharimmune Corp (THAR) - Return on Gross Profit|ADVB: Gross Margin|Return on Gross Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Gross Margin|Gross Return on Sales SBFM (Sunshine Biopharma)|Gross Profitability Xenetic Bio (XBIO)|Gross Profitability SLRX (Salarius Pharma)|Kitov Pharma - Return on Gross Profit|American Oncology Network (AONC) - Gross Profit Margin|BeiGene - Gross Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Gross Profit|ELEV (Elevation Oncology, Inc.) - Return on Gross Profit|iCAD Inc. - Gross Profit Rate|Return on Gross Profit IKNA|Gross Margin notablelabs.com|Return on Gross Profit VIRX (Viracta Therapeutics Inc.)|MOR - Gross Profit Margin|Gross Profitability NAYA Biosciences NAYA|AAPGV - Return on Gross Profit